S. Robinson

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

S. Montoto, N. Kröger, M. Robin, 2021, Haematologica.

Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT

N. Kröger, M. Robin, I. Yakoub-Agha, 2021, Bone Marrow Transplantation.

Myeloablative and Reduced-intensity conditioned Allogeneic Haematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of EBMT.

N. Kröger, L. Kanz, M. Robin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

H. Einsele, N. Kröger, M. Robin, 2019, Haematologica.

Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT

A. Ganser, M. Labopin, I. Yakoub-Agha, 2021, Blood Cancer Journal.

Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma

J. Sancho, T. Kinoshita, A. Davies, 2020, Annals of Hematology.

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

S. Montoto, J. Bourhis, N. Kröger, 2020, Bone Marrow Transplantation.

Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation

S. Montoto, P. Chevallier, D. Blaise, 2016, Leukemia.

Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study

M. Labopin, P. Veys, J. Wachowiak, 2021, Bone Marrow Transplantation.

Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor

E. Forcade, H. Finel, A. Boumendil, 2024, Bone marrow transplantation.

Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study

F. Baron, M. Mohty, F. Ciceri, 2023, British journal of haematology.